2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetonitrile, 95.0%, 5g

4-(4-Ethyl-piperazin-1-ylmethyl)-phenylamine, 95.0%, 5g

5-(4-methoxyphenyl)-4,5-dihydroisoxazole-3-carboxylic acid, 1g

Fmoc-Tyr(Bzl)-OH, 98%, 10g

3-(Methylsulfonylamino)phenylboronic acid, 97.0%, 10g

4-Methyl-2-(3,4-dichlorophenyl)thiazole-5-carboxylic acid, 95+%, 1g

4,7-Dibromo-1,10-phenanthroline, 95.0%, 1g

2-BROMO-5-(TRIFLUOROMETHOXY)PHENYLACETONITRILE, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,4-dichlorophenyl)propanoic acid, 97%, 5g

6-Fluoro-3-hydropyrazine-2-carboxamide, 95.0%, 25g

Nd-Z-D-ornithine methyl ester hydrochloride, 99.0%, 1g

anti-beta-actin, clone AC-15, mouse monoclonal, 1 ml

1-(thiophen-3-yl)cyclopropan-1-ol, 95.0%, 500mg